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Abstract
Background: Cerebral autoregulation (CA) is the brain’s ability to always maintain an adequate and rela-
tively constant blood supply, which is often impaired in cerebrovascular diseases. Near-infrared spectroscopy
(NIRS) examines oxygenated hemoglobin (OxyHb) in the cerebral cortex. Low- and very low-frequency oscil-
lations (LFOs ≈ 0.1 Hz and VLFOs ≈ 0.05 to 0.01 Hz) in OxyHb have been proposed to reflect CA.
Aim: To systematically review published results on OxyHb LFOs and VLFOs in cerebrovascular diseases and
related conditions measured with NIRS.
Approach: A systematic search was performed in the MEDLINE database, which generated 36 studies relevant
for inclusion.
Results: Healthy people have relatively stable LFOs. LFO amplitude seems to reflect myogenic CA being
decreased by vasomotor paralysis in stroke, by smooth muscle damage or as compensatory action in other
conditions but can also be influenced by the sympathetic tone. VLFO amplitude is believed to reflect neurogenic
and metabolic CA and is lower in stroke, atherosclerosis, and with aging. Both LFO and VLFO synchronizations
appear disturbed in stroke, while the former is also altered in internal carotid stenosis and hypertension.
Conclusion: We conclude that amplitudes of LFOs and VLFOs are relatively robust measures for evaluating
mechanisms of CA and synchronization analyses can show temporal disruption of CA. Further research and
more coherent methodologies are needed.
© The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of this work in whole or in
part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.NPh.5.3.030901]
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1 Introduction
Cerebral autoregulation (CA) of cerebral blood flow (CBF) is
the process in which the cerebral vasculature maintains a
relatively constant blood flow despite changes in perfusion
pressure.1 CA is impaired in several neurological diseases.2
The mechanisms and methods of investigating the CA have
been a subject of research and discussion ever since CA as
a concept was conceived.3 Both large arteries and small arteri-
oles contribute significantly to vascular resistance in the brain
and studies have shown that the large extracranial vessels (inter-
nal carotid and vertebral) and intracranial pial vessels contribute
to around 50% of cerebral vascular resistance (CVR).4 In recent
years, some of the most frequently used methods in studying CA
in humans have been transcranial Doppler (TCD) and near-
infrared spectroscopy (NIRS). TCD assesses blood velocity
in major cerebral vessels, whereas NIRS detects cerebral cortical
hemoglobin oxygenation and thereby changes in microcircula-
tory blood volume and flow. Both techniques can examine
low-frequent hemodynamic parameters with high temporal
resolution, but NIRS offers distinct advantages in being easy
to apply, operator-independent and directly measuring hemo-
dynamics in the cortical region of interest.
The aim here was to systematically review studies on low-
frequency oscillations (LFOs) and very low-frequency oscilla-
tions (VLFOs) measured by NIRS in cerebrovascular diseases
and related conditions to assess CA.
2 Background
2.1 Cerebral Autoregulation
The CA ensures that CBF is maintained at a relatively constant
level within large variations of arterial blood pressure (ABP) and
thus the cerebral perfusion pressure (CPP)1 (Fig. 1):
EQ-TARGET;temp:intralink-;e001;326;156CBF ¼ CPP
CVR
¼ ABP − intracranial pressure
CVR
: (1)
This serves as a protective measure against ischemia and fail-
ure could possibly result in pallor, sweating, confusion, dizzi-
ness, or syncope.7,8 In acute brain injury, where the tissue is
particularly sensitive, hypoperfusion can lead to progression
of the damages due to impaired CA7,8 and several neurologic
*Address all correspondence to: Adam Vittrup Andersen, E-mail: adam.vittrup
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disorders do exhibit impaired or changed CA.2 In the opposite
end of the arterial blood pressure (ABP) spectrum, CA also
protects against chronic hypertension and hypertensive
encephalopathy.9,10
Several factors influence CA. The myogenic mechanism is a
direct effect in smooth muscle due to changes in transmural
pressure mostly active in the small vessels of the brain.1,11–13
The endothelium has a prominent role by the release of dilatory
and constrictory substances in addition to the direct mechanical
response.1,13,14 Though no one single chemical agent has yet
been identified, a metabolic response is observed with neuronal
activation in local or global areas.1,11,13,15,16 Autonomic nerve
fibers richly innervate the cerebral vessels, especially the larger
arteries and activation of the sympathetic nervous system (SNS)
pushes the limits of the autoregulation plateau up higher
and vice versa.1,11,13,17,18 The level of the partial pressure of
carbon dioxide in arterial blood (PaCO2) also modifies CA
considerably.1,19 Hypercapnia increases CBF by vasodilation,
which also narrows the autoregulatory plateau with changes
of both the upper and lower CA limit. Hypocapnia decreases
CBF by vasoconstriction, but does not affect the lower limit
of CA, while uncertainty remains concerning the upper limit.
Furthermore, other physiological systems such as the renin–
angiotensin–aldosterone system and pharmacologic substances
can modify the complex nature of CA. The distribution of
resistance within the microvasculature is a contentious area of
research and especially the role of pericytes and capillary
resistance.20,21
The research on CA has developed in two main fields. Static
CA is the determination of the autoregulatory limits of ABP
under different relatively steady circumstances. Dynamic CA
includes investigations in both spontaneous physiological fluc-
tuations in ABP and CBF, but also the CBF response to sudden
changes in ABP, e.g., when changing body position or following
deflation of a cuff in order to quickly pool or release blood from
one or more extremities. The analysis of low-LFOs is a part of
dynamic CA, which we will be reviewing in the following.
2.2 Mayer Waves and Low-Frequency Oscillations
Mayer waves (M-waves) is a phenomenon of slow spontaneous
ABP oscillations observed in 1876 by Mayer in rabbits.22
Slower than ABP oscillations of cardiac (≈1 Hz) and respiratory
rhythms (≈0.2 to 0.5 Hz), these M-waves has different frequen-
cies across species, but about 0.1 Hz when observed in humans
(Fig. 2). M-waves are most often termed LFOs. The oscillations
in this frequency are believed to reflect sympathetic nervous
activity (SNA) as they are enhanced with activation of the SNS
and SNA have, therefore, often been attached to the definition of
LFOs.23 Their origin is thought to be the vasomotor tone of
blood vessels synchronous throughout the body,23,24 but the
driving mechanism behind the rhythmicity of the oscillations
has not yet been fully established.
2.2.1 Pacemaker theory and baroreceptor reflex theory
The pacemaker theory, primarily based on animal studies, sug-
gests that the central nervous system contains a pacemaker that
is responsible for the rhythmicity of LFOs.23 Studies have
shown slow SNA and ABP rhythms in the LFO frequency
despite the lack of sensory inputs from peripheral structures
in animals that have undergone surgical and/or medical
denervation.25–28 In tetraplegic humans with traumatic spinal
cord lesions, the results have been conflicting.29–31 While one
study showed consistent LFOs,31 other studies failed to detect
LFOs in some29 or all subjects30 perhaps due to different levels
of the spinal lesions or differences in tetraplegia durations as one
study proved significantly increased LFOs 6 months after the
initial examination.29
The baroreflex theory originates from the work of Guyton
and Harris.32 The contribution of the baroreceptor reflex to
the genesis of LFOs has since been confirmed in numerous
studies of animals undergone surgical sinoaortic baroreceptor
denervation33–35 showing either strong attenuation or abolish-
ment of LFOs. Deactivation of the baroreceptor reflex with
alpha-adreno blockers shows a similar trend in animals36–38
and humans.39,40 These studies support that the LFOs are caused
by vasomotor tone, because alpha-adrenergic antagonists block
the sympathetic effect on vasomotion.41
2.2.2 Amplitude
There are only a limited amount of studies focusing on the
amplitude of the LFOs. In animal studies the amplitude
follows the mean level of SNA when subjected to stimulations
altering the sympathetic tone.42–45 Human studies show the same
Fig. 1 Near-infrared spectroscopy (NIRS)-derived oxygen saturation
versus cerebral perfusion pressure (CPP), depicting the cerebral
autoregulation curve. With permission from Moerman et al.5 under
Creative Commons Attribution License. Original data from Brady et al.6
Fig. 2 OxyHb oscillations at cardiac frequency (1 Hz) and at M-wave
frequency (0.1 Hz) enhanced with deep breathing at 0.1 Hz.
Unpublished data from healthy elderly woman.
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tendency46–50 though only in individuals and not across groups
with different SNA levels51 perhaps due to age differences in the
vasculature and regulation thereof. The reproducibility of LFO
amplitudes is high over short-term, but low over long-term,52
though this could be influenced by several factors including
overall stress level.49 It has been suggested that the LFO
amplitudes indicates reflectory local myogenic activity53 in the
terminal arteriole smooth muscle cells,54 and is influenced by
sympathetic control mechanisms.55 It is thought that the local
myogenic response deals with small changes in systemic pres-
sure changes, while the SNS responds to larger changes,56 but
the exact relationship remains uncertain.
2.3 Very Low-Frequency Oscillations
Oscillations at an even lower frequency have been observed in
a range distinctly below LFOs (0.05 to 0.01 Hz). Originally
observed in intracranial pressure by Lundberg,57 these oscilla-
tions were also seen in ABP and velocity of the medial cerebral
artery (VMCA)
58,59 and termed VLFOs. The oscillations in these
different parameters have been shown to be connected and sev-
eral autoregulatory mechanisms have been proposed to explain
this connection.60–64
The origin of VLFOs is thought to be generated from
a central pacemaker because of the relation between different
oscillating parameters mentioned above, but also because of
the interhemispheric synchronicity.59,65–68 Rhythmic changes
in breathing and thereby changes in PaCO2 have also been
shown to attribute to VLFOs as they occur at about the
same frequency (≈0.03 Hz) and correlates well with blood-
oxygenation-level-dependent (BOLD) signals for CBF both
under steady state69,70 and with neural activity.71 CPP values
are described to have influence on the amplitude and frequency
of VLFOs,72 while they remain relatively independent of
changes in ABP. Intaglietta et al.54 proposed that they stem
from large arterioles under neurogenic innervation73 and
thus sympathetic control.74 In some cases, the VLFOs are
divided into two frequency ranges and Stefanovska et al.53
showed that while the upper VLFO range is endothelial inde-
pendent and probably relies on the neurogenic activity in large
arteries, the lower VLFO range is endothelial-related, and
therefore, connected to metabolic changes in the microvessels
(Table 1).
2.4 Physiological Function of Oscillations
The physiological purpose of the oscillations low in the frequency
spectrum remains intangible. Theories of cyclic nitric oxide (NO)
release from the endothelium beneficial to organ function75 and
a possible nutritive function76 from animal studies have not been
confirmed. The possibility remains that the oscillations are an
observed epiphenomenon with no functional purpose.77
2.5 LFOs and VLFOs in Evaluating Cerebral
Autoregulation
Similarities in existing knowledge of CA and origins of LFOs
and VLFOs indicate an association. Giller originally proposed
the method of coherence analysis between systemic and cerebral
perfusion oscillations in the low-frequency spectrum to evaluate
dynamic CA as the oscillations would be altered with intact CA
and relatively unaltered with impaired CA.60 Diehl et al.78 con-
trived the model of dynamic CA being a biologic control system
working as a high-pass filter transmitting high-frequent ABP-
oscillation unfiltered to CBF, while LFOs are filtered and
only passed through to CBF partially. Considering this, mea-
sures of gain and phase shift were suggested to quantify this
transmission and thus CA.
Katura et al.79 demonstrated that while an substantial amount
of the cerebral vessel LFOs can be attributed to systemic LFOs,
more than half cannot, indicating that the origin of cerebral LFO
may lie in the autoregulation of CBF rather than systemic
cardiovascular regulation.
While the high-pass filter model is not perfect, it does imply
two important features of LFOs that correlate with CA: the
amplitude and the synchronization. Especially, the latter has
been analyzed in different ways as healthy people exhibit highly
synchronized oscillations as an expression of well-functioning
central origin mechanisms and thereby intact CA. Feasibly, the
amplitude on the other hand could in part be ascribed to the
magnitude of autoregulatory mechanisms.
Table 1 Physiological ABP oscillations.
Oscillation Frequency (Hz) Factors considered to determine amplitude
Cardiac ≈1 Heart pumping
Respiratory ≈0.25 Respiration changing intrathoracic pressure
LFOs ≈0.1 Local myogenic activity in terminal arteriole
Influenced by sympathetic tone and control mechanisms
Upper VLFOs ≈0.05 Neurogenic SNS activity in large arteries
Spontaneous modulation of respiration frequency changing PaCO2 level
Independent of endothelium
Bottom VLFOs ≈0.01 Metabolic activity in microvessels
Dependent on endothelium
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2.6 Investigating Cerebral Low-Frequency
Oscillations
Spontaneous LFOs in cerebral vessels can be examined through
methods such as ultrasonic TCD 60 and NIRS,80 but they can
also be accentuated by stimulations of the same frequency.78,80
Both methods are equipped to examine the cerebral blood
circulation over time with high temporal resolution and can be
applied under various conditions and stimulations that cannot
be examined by more confined imaging modalities such as
BOLD-magnetic resonance imaging (MRI). While TCD esti-
mates the velocity in larger cerebral arteries such as the
MCA, NIRS investigates the cerebral tissue including all vascu-
lar compartments though quantitatively reflecting the microvas-
culature.81 The TCD method has dominated the CA research
over NIRS, despite TCD being challenged with certain assump-
tions and limitations. To assess CBF from measurements of
VMCA, it is assumed that the large arteries have a constant diam-
eter while studies have shown that the opposite is the case.82,83
Additionally, 5% to 20% of the population cannot be assessed
properly due to a poor acoustic window.84 Although NIRS has
other limitations and assumptions, at least the method offers
a direct measure of local CBF.
The method is simple to understand in general.81 Infrared
light of certain wavelengths between 650 and 950 nm is passed
from the skin through the extracranial layers and the cortex of
the brain. The light passes through human tissue being absorbed
by water, fat, melanin, and both oxygenated (OxyHb) and
deoxygenated hemoglobin (DeoxyHb). On the skin, adjacent
to the light source, detectors are that pick up the infrared signal
emanating from the body. Since the levels of water, fat, and
melanin remain constant, the signal can then be calculated into
dynamic OxyHb and DeoxyHb concentrations by a modified
version of the Beer–Lamberts law. To filter the extracranial sig-
nals from the intracranial signals, researchers often use multiple
light detectors with different distances from the light source and
separate the signals from each other to get the purest intracranial
signal possible85 (Fig. 3).
In the current study, we will address the NIRS modality
called continuous wave, which is not appropriate to calculate
an exact hemoglobin concentration as this comes with certain
assumptions. Rather, the signal is used to follow the dynamics
of the hemoglobin concentration and thereby the CBF in the
illumined portion of the cortex. NIRS cannot be used to examine
deeper parts of the brain.86
2.7 Data Analysis
Spectral analysis is needed to convert the raw NIRS signal into
oscillation parameters in the frequency domain. Only linear
models will be considered here, though nonlinear models
have shown comparable results.87 There are two common
ways of doing the spectral analysis of the NIRS signals: the
Fourier transform and the wavelet transform.
Time-domain analyses such as cerebral oximetry (Cox)
index,6 mean velocity (Mx) index,88 and tissue oxygenation
(Tox) index 89 will not be discussed in this paper as these analy-
ses differ too greatly from frequency-domain analysis to be com-
pared directly, despite being correlated to a certain degree.90
2.7.1 Fourier transform
The Fourier transform is commonly used to decompose a func-
tion of time, i.e., the NIRS signal, into a frequency domain.
There are many different variations of the Fourier transform.
Wewill address a couple of them here, but will not be discussing
them further in this paper. One of the variations can transform
the NIRS signals in the time domain, but this will not account
for specific frequency intervals, and therefore, is not suitable for
analyzing LFOs and VLFOs. The frequency domain analysis
generates certain frequency intervals, in which the oscillations
occur and the amplitudes of the oscillations in these frequency
intervals. A variation of this that is often used is called the fast
Fourier transform. It generates a measure called power spectral
density (PSD), which is the amplitude within a given signal in
relation to the frequency of the signal. The PSD and the ampli-
tude do not, however, say anything about the synchronicity of
the oscillations.
2.7.2 Transfer function analysis
The transfer function analysis (TFA) based on the Fourier trans-
form is used to detect synchronization of LFOs and VFLOs and
the method has been passed on from the TCD research
paradigm.60,78,91 It is a black box input–output analysis, gener-
ating ratios of the input signal that is transferred to the output
signal. In this context, the input can either be the ABP, mean
arterial pressure, or VMCA, and the output being the NIRS sig-
nals. The analysis produces two certain measures, gain and
phase shift. The gain is the amplitude of the input oscillations
relative to the amplitude of the output NIRS oscillations. Equal
amplitudes would, therefore, generate a gain of 1. The phase
shift (or phase angle) is a measure of synchronization and if
the oscillations occur at the exact same time the phase shift
would be 0 deg. If phase shift is negative, the input oscillations
occur before the output oscillations and vice versa, while a coun-
terphase relationship would generate a phase shift of 180 deg.
The input in a TFA can also be the NIRS signal of a healthy
hemisphere, which might serve as the best comparison if the
individual subjects have a healthy hemisphere.
2.7.3 Wavelet transform
The wavelet transform differs from the Fourier in that it trans-
forms data into a time-frequency domain, whereas Fourier can
only transform data into either frequency or time domain oneFig. 3 NIRS with short separation.
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at a time. This gives the transform some slight mathematical
benefits and some other possibilities. The downside is a
trade-off between spectral and temporal resolution. The wavelet
transform can, therefore, generate the amplitude of examined
oscillations, but also an instantaneous phase.92
In the NIRS oscillation research, the most commonly used
concepts are wavelet coherence (WCO) and wavelet phase
coherence (WPCO). WCO is a coherence determination of
both the amplitude and the relative phase shift at once. The
WCO is difficult to understand in the context of LFOs and
VLFOs as it is hard to dissociate the importance the amplitude
and the phase shift to the WCO. Instead, WPCO determines how
constant the phase difference is between to signals in a certain
frequency range. AWPCO of 1 means that the phase difference
between two oscillations constant over the entire time series,
whereas a WPCO of 0 would only be generated from two totally
independent oscillating signals.
Amplitude and phase of Fourier and wavelet transform can
be compared without conversion unlike synchronization analy-
sis (phase shift and WPCO).93 To our knowledge, the only stud-
ies using the two methods on the same group of patients are
conducted by Tachtsidis et al.24 and Rowley et al.55 showing
similar trends in PSD, while it is difficult to assess it quantita-
tively from the publicized results. Other methods are described
thoroughly and compared in an excellent review by Thewissen
et al.94 regarding NIRS investigations of CA in neonates.
3 Methods
3.1 Search Strategy
A systematic search of literature was conducted in MEDLINE
database through May 1, 2018. The search strategy was a com-
bination of the NIRS and oscillations concepts. Broad terms
were used to minimize the risk of missing any articles. The
full search strategy is depicted in Table 2.
The search resulted in 176 potentially relevant articles. In
addition, the identified articles’ reference lists were reviewed
to detect any relevant missing articles. This search resulted in
two additional articles. All 178 potentially relevant articles
were screened for relevance according to the following criteria.
3.2 Inclusion and Exclusion Criteria
To be included, studies had to use NIRS to examine cerebral
LFOs or VLFOs with frequency domain analysis in cerebro-
vascular diseases or related conditions preceding them including
aging. Studies of healthy populations were also included as an
indicator of normal variations, though articles focusing on tech-
nical or analytical aspects were excluded. Traumatic brain injury
patients and intraoperative monitoring were excluded. Only
original peer-reviewed studies presenting own results were
included leading to the exclusion of reviews. The process is
depicted in Fig. 4.
4 Results and Discussion
Thirty-six studies were included and reviewed. Studies were di-
vided into four categories based on study population: healthy
subjects, cerebral diseases with structural brain damage, symp-
tomatic cerebrovascular disease with increased risk of further
cerebrovascular damage, and asymptomatic populations with
increased risk of cerebrovascular disease. Some studies over-
lapped these categories.
In the following, only OxyHb data will be included in the
discussion. The DeoxyHb data conceivably have interesting
findings, especially in functional activation studies and when
comparing to BOLD-MRI measurements. However, the
observed DeoxyHb-changes are mainly a reflection of the
venous compartments, whereas OxyHb represents all vascular
compartments.95 Additionally, the dynamic changes in OxyHb
are closer related to the vascular compartments where CA is
most active,6,96 and the OxyHb signals are more robust and
Table 2 Search strategy.
AND
NIRS concept Oscillations concept Filters
“Spectroscopy, NIR” [MeSH]
OR
NIRS
OR
“NIR spectroscopy”
OR
“Cerebral oximetry”
OR
“Cerebral oxygenation”
OR
“Cerebral oxygen saturation”
Oscillation(s)
OR
Fluctuation(s)
OR
“M-wave(s)”
OR
M-wave(s)
OR
Vasomotion
OR
LFO(s)
OR
VLFO(s)
OR Fourier
OR
Wavelet
OR
“Transfer function”
OR
Transform
AND
Amplitude(s)
OR
Gain
OR
“PSD”
OR
PSD
OR
Phase(s)
OR
Phase shift
OR
WPCO
Humans [MeSH terms]
AND
Adults [MeSH terms]
AND
English language [MeSH terms]
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also more reliable in the topical frequency spectrum97 making it
the most suitable for evaluating CA. The transform parameters
have been discussed previously.
Due to the heterogeneity of technical and analytical methods,
no quantitative measures are listed in this section. Rather, results
are presented as comparative measures as all studies in this area
of research use some sort of control group. Most studies had
a healthy control group, while others compared different stages
of a disease or one hemisphere to the contralateral.
4.1 Healthy Subjects
In a seminal study, Reinhard et al.98 measured LFOs in ABP,
VMCA and OxyHb in a healthy elderly population. The VMCA
LFOs preceded the ABP LFOs, which were again slightly
ahead of OxyHb LFOs. All LFOs were highly correlated with
each other and so the phase shifts merely represent a temporal
lag between which vessels the oscillations are measured from
Fig. 5. This finding was later confirmed in healthy young people
by Philip et al.,99 who additionally showed equal phase shifts
across gender, between left and right hemispheres, and over
time. Neither visual,80 respiratory,99,100 motoric,101 nor posi-
tional stimulations24 have caused any significant changes in
the synchronization of LFOs. However, desynchronization has
been shown with poor sleep quality in healthy elderly102 and
with sleep deprivation in healthy young people.103
In contrast, the amplitude of OxyHb LFOs is sensitive to
stimulations and increases with sympathetic stimulations,24,100
deep breathing,100 and poor sleep,102 diminishes with hypercap-
nia,80 while visual stimulations did not affect them. No difference
has been observed across gender or between hemispheres, but
the day-to-day amplitude ratio seems to fluctuate considerably.99
Very little corresponding knowledge has been obtained about
the normal variance of OxyHb VLFOs.
4.2 Cerebral Diseases with Structural Brain
Damage
The studies in Table 3 were identified.
4.2.1 Amplitude
In ischemic stroke occurring more than 12 months ago, the
amplitude of both LFOs and VLFOs was shown to be lower
than in healthy age-matched controls.104 Phillip et al.105 inves-
tigated LFOs of acute ischemic strokes within 5 days of ictus,
but did not examine a healthy control group. Thrombolysed
patients, conceivably having suffered less damage to their
brain, exhibited amplitudes equal to that of nonthrombolysed
patients. The absolute amplitude ratio was borderline different
between the two group and amplitude did not correlate with
NIHSS on admission. According to the prevailing oscillation
theories, decreased amplitudes would indicate a lower mean
SNA or less myogenic (LFO) as well as neurogenic and meta-
bolic (VLFO) autoregulatory activity. The former does not cor-
relate with the common understanding of the autonomic nervous
system (ANS) after stroke, where the SNS is believed to be over-
active and dominating over the relatively inert parasympathetic
nervous system.106 However, the smooth muscle loses its tone
after a stroke, which is an effect known as vasomotor paralysis.1
The ability to contract is a prerequisite for the SNS to raise LFO
Fig. 4 PRISMA flow diagram.
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amplitude not being met due to the stroke. The decline in myo-
genic CA activity is an indication of the vasomotor paralysis
rendering the brain vulnerable to further damage and could be
permanent as it can be observed at least 12 months at minimum
after a stroke.
Schroeter et al.107 found a decreased LFO amplitude in
patients with cerebral microangiopathy (CMA), though only
due to hypertension. The amplitude of VLFOs in this study
increased with visual stimulation supporting the theory of
VLFO amplitude as in indication of possible metabolic control
mechanism (though the applied range was an aggregate of met-
abolic and neurogenic VLFO frequencies). As CMA patients
have damaged small vessels, one would have expected altered
VLFO amplitude compared to the control group as the meta-
bolic control occurs in the small vessels, but this was not the
case possibly due to the aggregate VLFO range applied.
Newly diagnosed Alzheimer’s (AD) patients exhibited a
higher LFO amplitude at rest in a study by van Beek et al.108
The increased myogenic activity could be explained by a higher
mean SNA level as shown in studies of the ANS in AD.109–111 The
difference in LFO amplitude vanished when the groups per-
formed a repetitive sit–stand maneuver possibly because of
the SNS responding to large ABP-changes in healthy controls.
VLFO amplitude was equivalent in the two groups under both
conditions expressing equal neurogenic and metabolic CA
activity.
ATFA of these patients showed that gain between VMCA and
OxyHb VLFOs was increased compared to controls, which
authors proposed as an indicator of reduced metabolic reserve
or a reduced diffusion of oxygen as observed in positron emis-
sion tomography studies of AD. The LFO VMCA-OxyHb gain
amplitude was similar across the two groups.
4.2.2 Synchronization
Several studies have explored the LFOs in resting patients
with a chronic cerebral infarction and all found a lower interhe-
mispheric WPCO in stroke patients suggesting a lesser stability
of the phase difference between the hemispheres compared to
healthy people.112–114 This effect was interpreted as a loss of
the control on myogenic CA activity in the smooth muscle
of resistance vessels. Such a desynchronization was also seen
in acute stroke as evidenced by a higher absolute interhemi-
spheric phase shift.105 Interestingly, the interhemispheric phase
Fig. 5 Physiological phase relationship between oscillations in ABP
and different cerebral hemodynamic parameters. Schematic illustra-
tion of oscillations. SumHb ¼ OxyHbþ DeoxyHb. DiffHb ¼ OxyHb −
DeoxyHb. With permission from Reinhard et al.98
Table 3 Included studies of cerebral diseases with structural brain damage.
Authors Population Signals Oscillations Frequency range (Hz) Analyses
Phillip et al.105 Acute stroke OxyHb LFO 0.09 to 0.11 Amplitude and synchronization
Li et al.104 Chronic stroke OxyHb LFO 0.04 to 0.15 Amplitude
Upper VLFO 0.02 to 0.04
Han et al.112 Chronic stroke OxyHb LFO 0.052 to 0.145 Synchronization
Upper VLFO 0.021 to 0.052
Han et al.113 Chronic stroke OxyHb LFO 0.052 to 0.145 Synchronization
Upper VLFO 0.021 to 0.052
Tan et al.114 Chronic stroke OxyHb LFO 0.052 to 0.145 Synchronization
Upper VLFO 0.021 to 0.052
Bottom VLFO 0.0095 to 0.021
Schroeter et al.107 CMA OxyHb LFO 0.07 to 0.12 Amplitude
Upper VLFO 0.01 to 0.05
van Beek et al.108 AD VMCA LFO 0.07 to 0.13 Amplitude and synchronization
OxyHb Upper VLFO 0.02 to 0.07
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shift proved to be well correlated to the National Institutes of
Health Stroke Scale (NIHSS) and so the impaired CA was
due to stroke size and not to treatment (thrombolysis or not).
VLFOs in the upper range exhibited lower interhemispheric
WPCO in chronic stroke than control groups in two stud-
ies,112,114 while another showed an equal WPCO though with
a smaller sample size.113 Lower WPCO would indicate a disrup-
tion of spontaneous neurogenic CA activity. Tan et al.114 also
inspected the oscillations in the bottom VLFO range, which
also had a lower WPCO and thus a reduced synchronicity of
the metabolic control mechanism.
AD patients displayed a higher VMCA-OxyHb phase shift in
the VLFO range and authors explained this as differences in
either active regulation mechanisms or in passive properties
in the cerebral vasculature.108 They also found an equal phase
shift in the LFO range suggesting intact coordination of myo-
genic CA.
4.3 Symptomatic Diseases with Increased Risk of
Further Damage
The studies in Table 4 were identified.
Studies of migraine, obstructive sleep apnea (OSA), and
malaria were included in the review, though the risk association
to cerebrovascular disease is not strong enough to draw any def-
inite conclusions. However, these diseases have cerebrovascular
traits that make them interesting in this context.
4.3.1 Amplitude
Symptomatic carotid stenosis (CS) patients were examined by
Phillip et al.,115 which revealed equal gain between ABP and
OxyHb LFOs when comparing to both the contralateral hemi-
sphere and the hemispheres of healthy controls. However, an
interhemispheric TFAwas performed and showed a higher ampli-
tude ratio due to lower amplitude on the hypoperfusion side.
This indicates lower myogenic activity in the microvasculature
distal to the stenosis as an expression of compensatory dilation
due to inadequate perfusion and oxygen delivery.
Moyamoya disease is characterized by intimal proliferation
and stenosis of both the internal carotid arteries as well as its
intracranial branches thereby creating the need for collateral
angiogenesis looking like a dust cloud on angiography.116
The disease was inspected with NIRS, which showed lower
amplitude in the LFO range and bottom VFLO range.117
In accordance with histological studies proving smooth muscle
degeneration as the intima grows expansively,118 this result
points to a decrease in spontaneous smooth muscle activity.
Schytz et al.119 examined both patients with familial
hemiplegic migraine (FHM), common migraine, and OSA.120
Patients suffering from FHM combined with common migraine
had induced attacks with infusion of glyceryl trinitrate, and this
was accompanied by higher LFO amplitude possibly caused by a
reflectory increase in SNA and smooth muscle tone. OSA patients
were examined before and 2 months after initiation of continuous
positive airway pressure (CPAP) treatment. Oddly, OSA patients
did not exhibit any difference to controls in LFO amplitude before
CPAP despite OSA usually raising the general sympathetic
tone121 and thus the smooth muscle activity, but perhaps this
was disrupted by endothelial damage also associated with
OSA120. However, they displayed a significant decline after treat-
ment, reflecting the expected modulation of sympathetic activity.
In malaria patients, no difference in LFO amplitude was
detected between cerebral and noncerebral malaria.122 Upper
VLFO amplitude, however, was lower in cerebral malaria
perhaps demonstrating the changes in microvasculature flow
prompted by the parasite.123 Authors state an increase in VLFO
amplitude after recovery, but with no mention of which patients
were included in the follow-up analysis.
4.3.2 Synchronization
CS has been under scrutiny by TFA due to the inherent nature of
the disease. Reinhard et al.98 were first to investigate it with
Table 4 Included studies of symptomatic diseases with increased risk of further damage.
Authors Population Signals Oscillations Frequency range (Hz) Analyses
Reinhard et al. 98 Unilateral CS ABP LFO ≈0.1 Synchronization
VMCA
OxyHb
Phillip et al. 115 Symptomatic CS ABP LFO 0.09 to 0.11 Amplitude and synchronization
OxyHb
Reinhard et al.124 Unilateral CS ABP LFO 0.095 to 0.105 Synchronization
OxyHb
Oldag et al. 126 Severe unilateral MCA stenosis ABP LFO 0.08 to 0.12 Synchronization
OxyHb
He et al. 117 Moyamoya OxyHb LFO 0.06 to 0.15 Amplitude
Upper VLFO 0.02 to 0.06
Bottom VLFO 0.0095 to 0.02
Schytz et al. 119 FHM ± common migraine OxyHb LFO 0.09 to 0.11 Amplitude
Schytz et al.120 OSA OxyHb LFO 0.05 to 0.15 Amplitude
Kolyva et al.122 Malaria OxyHb LFO 0.04 to 0.15 Amplitude
Upper VLFO 0.02 to 0.04
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NIRS as the output measure. Compared to both healthy controls
and the contralateral hemisphere, respiratory amplified LFOs in
VMCA and OxyHb were delayed relative to ABP LFOs, but only
the phase shift to the former was statistically significant. The
normal counterphase relationship of OxyHb–DeoxyHb was
also abrogated. These changes point to a desynchronization
and thus impaired CA. Results from such patients must be care-
fully treated, as it is difficult to dissociate the effect of CS from
other risk factors and infarction, though only a minor portion
had any symptoms in this study. Authors later solidified their
findings in an examination using a multichannel NIRS system,
which also showed CA being mostly impaired in the MCA/ACA
(anterior cerebral artery) border zone.124
Similarly, Philip et al.115 arrived at a borderline altered phase
shift when comparing to the contralateral hemisphere in resting
symptomatic CS patients also demonstrating an impaired CA,
but no difference compared to healthy controls. Using interhe-
mispheric OxyHb TFA, authors presented an altered absolute
interhemispheric phase shift with borderline significance.
Interhemispheric measures seem more intuitively correct as it
would minimize anatomical variations125 despite the noteworthy
limitation of needing a healthy contralateral hemisphere to
compare with.
The trend also occurs in severe unilateral MCA stenosis
although the examined patients were asymptomatic. Increased
LFO ABP-OxyHb phase shift was observed in the affected
hemisphere over the entire hemisphere and even higher in the
core MCA distribution area.126 A subgroup was examined for
CVR, which showed that diminished CVR led to higher
phase shifts. The desynchronization of myogenic CA could
thus be the consequence of the downstream vessels not being
able to compensate for the MCA stenosis.
4.4 Asymptomatic Conditions with Increased Risk of
Cerebrovascular Disease
The studies in Table 5 were identified.
Table 5 Included studies of asymptomatic conditions with increased risk of further damage.
Author Population Signals Oscillations Frequency range (Hz) Analyses
Li et al.128 Risk of stroke − elevated VMCA OxyHb LFO 0.06 to 0.15 Amplitude
Upper VLFO 0.02 to 0.06
Bottom VLFO 0.005 to 0.02
Li et al.129 Hypertension ± elevated VMCA OxyHb LFO 0.06 to 0.15 Amplitude
Upper VLFO 0.02 to 0.06
Bottom VLFO 0.005 to 0.02
Li et al.138 Hypertension OxyHb LFO 0.05 to 0.15 Synchronization
Upper VLFO 0.02 to 0.05
Zeller et al.130 Elderly ± MCI OxyHb LFO 0.07 to 0.11 Amplitude
Schroeter et al.131 Elderly OxyHb LFO 0.07 to 0.11 Amplitude
Upper VLFO 0.01 to 0.05
Peng et al.136 Elderly HR LFO 0.0625 to 0.125 Amplitude and synchronization
ABP
VMCA
OxyHb
Philip et al.99 Elderly ABP LFO 0.09 to 0.11 Amplitude and synchronization
OxyHb
Li et al.132 Elderly OxyHb LFO 0.06 to 0.15 Amplitude
Upper VLFO 0.02 to 0.06
Bottom VLFO 0.0095 to 0.02
Vermeij et al.135 Elderly ABP LFO 0.07 to 0.2 Amplitude and synchronization
OxyHb Upper VLFO 0.02 to 0.07
Oudegeest-
Sander et al.137
Elderly VMCA LFO 0.07 to 0.2 Amplitude and synchronization
OxyHb Upper VLFO 0.02 to 0.07
Cui et al.140 Elderly ABP LFO 0.05 to 0.15 Synchronization
OxyHb Upper VLFO 0.02 to 0.05
Bottom VLFO 0.0095 to 0.02
Gao et al.139 Elderly ABP LFO 0.05 to 0.15 Synchronization
OxyHb Upper VLFO 0.02 to 0.05
Bottom VLFO 0.0095 to 0.02
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4.4.1 Amplitude
Elevated VMCA has been recognized as a measure of intracere-
bral atherosclerosis, and therefore, a risk factor for stroke.127
People with this condition displayed lower amplitude in LFO,
upper and bottom VFLO ranges, though the former two were
borderline significant.128 This provides indication of decreases
in myogenic, neurogenic, and metabolic activity of the cerebral
vasculature with elevated VMCA, which could all be attributed to
the stiffening of vessel walls in atherosclerosis.
An important factor in the development of atherosclerosis is
arterial hypertension, in which Li et al.129 examined with half of
the hypertension subjects also exhibiting elevated VMCA.
Hypertension increased the LFO amplitude as the result of myo-
genic autoregulatory mechanisms being activated to protect
the brain in conform to general CA knowledge.1 The group
with elevated VMCA had amplitudes between that of the hyper-
tension group and the healthy controls. This dampening of
amplitude consolidates the findings in the former study of
elevated VMCA.
128 Noteworthy is the opposite trend of LFO
amplitude in CMA patients as the result of hypertension107 pos-
sibly elucidating that CMA patients do not have the ability to
increase their myogenic CA in response to the challenge of
hypertension. VLFO amplitudes did not show any definite
trends in hypertension.
LFO amplitude has been shown to decrease with age in
numerous studies with subjects both at rest130,131,132,133,134 and
with stimulations of visual,131 cognitive,135 and positional
character.136,133 Generally, this has been interpreted as an
expression of vessel stiffening with age, and therefore, less
microvascular smooth muscle activity. This trend was even
more pronounced in elderly with mild cognitive impairment
(MCI), though only in the parietal lobes.130 TFA showed no
difference in LFO ABP-OxyHb gain across age groups during
rest99,135 or cognitive memory task.135
VLFO amplitude in aging exhibited a similar decline132
although more apparent with stimulations131,135,133 displaying
an age effect on neurogenic and metabolic CA. TFA of ABP-
OxyHb VLFO during the cognitive test by Vermeij et al.135
showed no effect of age or cognitive load on gain.
During sit–stand maneuvers performed in a study by
Oudegeest-Sander et al.,137 authors found no difference in
VMCA-OxyHb gain across age groups, but a trend toward higher
gain was conveyed in their regression analysis. Reduced disten-
sibility and thereby less damping of VMCA oscillations in the
elderly were proposed to account for this difference.
4.4.2 Synchronization
The interhemispheric WPCO approach was applied to hyperten-
sion patients and resulted in lower LFO WPCO and equal
WPCO in the upper VLFO range.138 This loss of synchronicity
was connected to a reduced control of the microvascular smooth
muscle activity. The stroke study by Han et al.112 examined
a subpopulation also suffering from hypertension and found
an even lower WPCO in the upper VLFO range suggesting
additional desynchronization of neurogenic CA activity, while
hypertension did not desynchronize LFOs any further.
The synchronization of oscillations in the aging brain has
been well examined. Peng et al.136 used a synchronicity analysis
called wavelet cross correlation (WCC, higher values indicating
stronger synchronicity). It showed that the WCC for HR-
OxyHb, ABP-OxyHb, and VMCA-OxyHb was equal in the
LFO range when subjects remained at supine rest but increased
substantially more in young people with head-up tilt test and
with active standing in another study.139 This implies an increase
in synchronization between systemic and CBF under sympa-
thetic challenges such as positional changes and that this mecha-
nism is impaired in the elderly.
ABP-OxyHb LFO phase analyses have disclosed equal
phase shifts in young and elderly under rest99,135 and during cog-
nitive testing.135 Wavelet studies have come to the same conclu-
sion, as the ABP-OxyHb WPCO was homogenous across age
groups at rest.140,139 Meanwhile, interhemispheric analyses
found lower WPCO with aging indicating desynchronization
of myogenic CA at rest.134,141
Oudegeest-Sander et al.137 examined the VLFOs during a sit-
stand maneuver and their regression analysis showed a trend
toward higher VMCA-OxyHb phase shift with age explained
by increased vascular tortuosity. The WPCO between VLFOs
of ABP and OxyHb in the elderly has also been investigated.
At rest synchronization of neurogenic CA activity was higher
in the elderly perhaps to compensate for the decline in myogenic
CA activity.140,139 During active standing, this difference evened
out and both the neurogenic and metabolic CA synchronization
was equivalent to the young.139 Interhemispheric WPCO analy-
sis also showed intact synchronization of metabolic and neuro-
genic activity.134
5 Limitations
Before making any definitive conclusions based on the reviewed
material, several limitations must be acknowledged. The pen-
etration depth of infrared light prevents NIRS from ever
Table 5 (Continued).
Author Population Signals Oscillations Frequency range (Hz) Analyses
Song et al.133 Elderly OxyHb LFO 0.06 to 0.15 Amplitude
Upper VLFO 0.02 to 0.06
Bottom VLFO 0.01 to 0.02
Tan et al. 134 Elderly OxyHb LFO 0.052 to 0.145 Amplitude and synchronization
Upper VLFO 0.021 to 0.052
Bottom VLFO 0.0095 to 0.021
Wang et al.141 Elderly OxyHb LFO 0.052 to 0.145 Synchronization
Upper VLFO 0.021 to 0.052
Bottom VLFO 0.0095 to 0.021
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examining deeper parts of the brain than the available cortex and
can never be used to determine whether the observations are
reflecting global hemispheric trends or local phenomena despite
the use of multichannel systems. In general, the reviewed exami-
nations have applied an interoptode distance of 3 to 5 cm to get
the deepest penetration possible, but with no coherency across
studies. Although signals from the skin and skull could pollute
the cortical signal, the method of short separation optodes rec-
tifies this shortcoming in most cases.
NIRS assumes that the infrared light passes through tissue
with a constant spread and that only hemoglobin absorbs the
light, which are both reasonable. The emanating signal is com-
prised of the entire tissue and all the different vascular compart-
ments, which is hard to separate and only recently made
conceivable with NIRS.142 The infrared light in the spectrum
utilized has a wavelength between 650 and 950 nm, but there
is no unified agreement, in which exact wavelengths are
most appropriate. Because the relative absorption of OxyHb
and DeoxyHb changes with the wavelength, there is a difference
between the measured chromophores and thus the examined
vascular compartment when using different wavelengths.95,143
NIRS also assumes that the measured hemoglobin concentration
is the homogenous in the illuminated tissue, which is not nec-
essarily the case, especially when local pathology is involved.
Processing NIRS signals can be done in a variety of ways to
remove motion artefacts and while every process has its advan-
tages, none have proved to be superior to others. The technique
is more sensitive to motion artefacts than it is credited for, which
will either limit the possible functional stimulations or raise the
requirements for postprocessing.
The spectral analysis of NIRS signals can either be per-
formed with Fourier or wavelet transforms and while the two
methods are mathematically equivalent, the outcomes in the
synchronization analysis cannot be compared directly. Also
the differences in technical setup, postprocessing, and spectral
analyses render any sort of metaanalysis impossible.
The oscillation analysis method is quite demanding in several
ways. The nature of LFOs requires rather long recordings to
build a significant data foundation as LFOs only occur 6
times per minute and VLFOs 1 to 3 times per minute. The analy-
sis itself is quite complex and commands skilled personnel and
time. Also, as shown in Tables 3–5, there is a need for coherency
in the applied frequency ranges. These factors constitute a sub-
stantial obstacle of monitoring for immediate changes in CA and
thus the clinical implementation.
In this paper, both spontaneous oscillations and oscillations
enhanced with stimulations of appropriate frequency have been
included. Debate remains between scientists as to which method
is better.144 While spontaneous oscillations are claimed to have
higher signal-to-noise ratio, this could be accounted for in the
analysis and provide a reasonable method for evaluating CA in
patients where stimulations can be challenging to perform,
e.g., stroke or other cerebrovascular diseases.
Average population size in NIRS oscillation studies is not
particularly large and the need for larger-scale investigations
is obvious in order to solidify the current knowledge and show-
case the possible clinical utilization. However, the technique
suffers somewhat due to the perpetual technical and analytical
development quickly causing results to be viewed as either out-
dated or inappropriate for comparison with other studies. It also
makes the continuous examination of healthy control groups
imperative. There have not yet been established any quantitative
measure of intact or impaired CA, which also leaves power
calculations impossible.
Caution should be advised in the oscillation research, as
investigation of too many oscillating chromophores and
NIRS parameters could potentially be more misleading than
progressive. The absence of focus in both study design and
outcome is dangerous when dealing with relatively small
sample sizes. Additionally, the term “altered oscillations” is
often applied in discussions of results across different parame-
ters and should be avoided. Each parameter should be carefully
analyzed separately as the current study has attempted.
More research is clearly needed both in experimental and
clinical studies to improve our knowledge of the oscillations
in general and expand the pathophysiological understanding
of cerebrovascular diseases and conditions that lead to them.
The method would benefit greatly from more coherent technical
and analytical procedures, while advances in these areas could
also provide the basis for implementation in clinical settings.
6 Conclusion
CA is a complex phenomenon ensuring adequate perfusion to
the brain by myogenic, neural, metabolic, and possibly other
mechanisms. The modulation of systemic oscillations in the
low- and very low-frequency spectrum measured in cerebral
vessels is thought to be an expression of the exerted autoregu-
lation. Near-infrared spectroscopy can be used to examine
regional cerebral perfusion and thus evaluate CA in cerebro-
vascular diseases and related conditions. The outcome of
LFO amplitude is relatively robust in quantifying the myogenic
CA from the smooth muscle cells in the microvasculature, which
is lower in stroke, atherosclerosis, and with aging, but must be
interpreted with great care as it can be affected by sympathetic
activity as in hypertension. LFO synchronization analyses of
oscillations have shown disruption of normally well-coordinated
autoregulatory actions in stroke, internal carotid, and MCA
stenosis as well as in hypertension in accordance with other
measurement techniques, but the optimal comparison remains
uncertain. VLFO amplitudes suggest lower metabolic and
neurogenic CA in stroke, atherosclerosis, and aging, but are gen-
erally not as consistent as LFO amplitude, in part due to inco-
herent frequency ranges. VLFOs are desynchronized in stroke,
intact in hypertension, and with aging. Although the outcomes
can never stand alone, they seem able to enhance our knowledge
of CA. Despite certain limitations, the oscillation analysis of
NIRS data could be a valuable tool to both researchers and
physicians in the future. Additional research and more coherent
methodologies are needed.
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